STAT

JULY 11, 2023

” Though he was a formidable philosopher and logician, Carroll likely would be stymied by the circular logic that justifies the definition of “recovery” currently used to support critical federal substance use disorder programs and activities. Read the rest…

75

75

BioPharm

SEPTEMBER 19, 2023

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

FDA 52

FDA 52

Fierce Healthcare

SEPTEMBER 15, 2021

Definitive Healthcare hauls in $420M in IPO, joining steady stream of health tech firms to go public. Wed, 09/15/2021 - 10:17.

121

121

Pharmacy Times

SEPTEMBER 29, 2023

A workgroup of asthma treatment experts introduced 6 new criteria that those diagnosed with asthma must meet to be in remission.

131

131

Fierce Healthcare

JANUARY 16, 2024

Industry Voices—Oncology researchers must rethink their definition of what is considered a "good" clinical research site hlandi Tue, 01/16/2024 - 12:49

52

52

STAT

APRIL 18, 2024

In the chaotic first few months of the Covid-19 pandemic, stores faced shortages of all kinds — toilet paper, canned food, and especially, cleaning supplies. With everyone scrubbing their groceries, mail, even library books, good luck finding antibacterial wipes or disinfectant sprays back then.

145

145

STAT

AUGUST 17, 2023

When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope.

98

98

Pharma Mirror

JANUARY 22, 2022

Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy’s Laboratories Limited (DRL).

52

52

Pharmacy Times

APRIL 26, 2023

The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.

132

132

STAT

AUGUST 17, 2023

There are people in your life who influence and shape how you see the world. For me, one of these people is Terry Moakley, a warm and welcoming family friend, a veteran of the Vietnam War, and a fervent advocate for people with disabilities.

96

96

Fierce Healthcare

NOVEMBER 7, 2024

Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday.

78

78

Pharmaceutical Technology

NOVEMBER 14, 2024

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a programmed death-ligand 1 and vascular endothelial growth factor A-targeting bispecific antibody.

98

98

PharmExec

JANUARY 18, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

pharmaphorum

MARCH 24, 2021

This two-day virtual event is a definitive guide for anyone working with RBQM – from experts to beginners. The post RBQM Live: The Definitive Guide to RBQM for Experts and Beginners appeared first on. You can register now for a free E-Pass. More expert speakers will be announced shortly so keep an eye on the website for updates.

52

52

PharmExec

OCTOBER 23, 2023

Deal includes rights to novel antibody for the treatment of inflammatory bowel disease.

52

52

PharmExec

OCTOBER 30, 2023

Merger expected to expand company’s existing complementary platform of organ manufacturing programs.

59

59

Pharmafile

MARCH 27, 2023

NASDAQ: JNCE) ("Jounce"), that it has entered into a definitive merger agreement to be acquired by Concentra Biosciences, LLC. NASDAQ: JNCE) ("Jounce"), that it has entered into a definitive merger agreement to be acquired by Concentra Biosciences, LLC. read more

40

40

Drug Topics

MARCH 6, 2023

Endometriosis has been linked with autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, but more definitive research is needed

185

185

STAT

NOVEMBER 14, 2024

The company is collecting the least amount of data possible from single-arm, open-label studies that, by definition, will not demonstrate convincing proof of efficacy or safety.    Yet at Neurogene, the developer of a gene therapy for Rett syndrome, expediency seems to be the priority.

Labelling 122

Labelling 122

STAT

SEPTEMBER 4, 2024

And they were definitely failing. There it was on James Cannon’s lab report, two tiny words: African American. The words sat next to a number estimating how badly Cannon’s kidneys were failing. His number read 37, less than half of what is considered normal for adults.

Labelling 131

Labelling 131

PharmExec

MAY 31, 2024

Under terms of the deal, Akili will become a wholly owned subsidiary of Virtual Therapeutics, with Akili shareholders receiving $0.4340 per share of common stock in cash.

52

52

Pharmacy Times

JANUARY 4, 2024

Perhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.

145

145

PharmExec

DECEMBER 5, 2022

The transaction allows TherapeuticsMD to recapitalize and transform into a pharmaceutical royalty company while giving Mayne Pharma exclusive U.S. commercialization rights for their products.

52

52

Pharmaceutical Technology

NOVEMBER 11, 2024

AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris Therapeutics, to create a new entity focused on developing therapies for retinal diseases.

52

52

STAT

SEPTEMBER 25, 2024

“And we definitely want to position Akeso as a global biotech, not just a China story.”    Now, Akeso’s leaders want you to know that its recent success isn’t a one-off.  ”  Continue to STAT+ to read the full story…

142

142

STAT

NOVEMBER 19, 2024

To start, FDA officials wrote in an executive summary shared before the meeting, it’s hard to know when it qualifies as a device under the agency’s definitions.     Why is it so hard to regulate generative AI products in medicine?   Continue to STAT+ to read the full story…

FDA 102

FDA 102

Pharmacy Times

SEPTEMBER 26, 2023

This disease can, at the very least, help researchers to “identify” the floodgates to definitive tests and therapies for complex psychological and neurological diseases, expert says.

132

132

Pharmaceutical Technology

NOVEMBER 7, 2024

Funds managed by GHO Capital Partners and Ampersand Capital Partners have signed a definitive agreement to acquire Avid Bioservices.

52

52

Pharmaceutical Technology

MAY 23, 2024

Merck KGaA’s MilliporeSigma has entered a definitive agreement for the acquisition of Mirus Bio in a deal totaling $600m (€500m).

104

104

Pharmaceutical Technology

NOVEMBER 5, 2024

Nektar has signed a definitive agreement to divest its Huntsville facility and associated reagent supply business to Ampersand

52

52

Pharmaceutical Commerce

MARCH 17, 2023

Industry is still scrambling to handle clerical errors of DSCSA transactions.

FDA 52

FDA 52

Fierce Pharma

JULY 22, 2024

Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag.

106

106

Pharmaceutical Technology

OCTOBER 29, 2024

AbbVie has entered a definitive agreement to acquire all outstanding equity of Aliada Therapeutics in a deal valued at $1.4bn in cash.

52

52

Pharmafile

JUNE 25, 2024

The two companies are currently working to finalise a definitive agreement for the collaboration. ILiAD Biotechnologies has announced that it has selected Emmes Group to conduct the upcoming phase 3 trials of its lead pertussis vaccine candidate, BPZE1.

Vaccines 97

Vaccines 97

Fierce Healthcare

JUNE 21, 2024

Kaiser Permanente’s Risant Health has named North Carolina’s Cone Health as the second acquisition target on its path toward a multisystem, multiregional value-based care entity. | The definitive agreement to purchase the $2.8 Terms and a timeline were not disclosed.

133

133

PharmaShots

MAY 1, 2023

Shots: Astellas to acquire 100% of the outstanding shares of Iveric Bio for $40.00/share share in cash for a total equity value of ~$5.9B outstanding shares of Iveric Bio common stock on a fully diluted basis representing 22% premium to $32.89 closing price.

FDA 40

FDA 40

PharmaShots

MAY 1, 2023

Shots: Astellas to acquire 100% of the outstanding shares of Iveric Bio for $40.00/share share in cash for a total equity value of ~$5.9B outstanding shares of Iveric Bio common stock on a fully diluted basis representing 22% premium to $32.89 closing price.

FDA 40

FDA 40